Considering surgical out-patient attenders with no history or signs of anal warts, 25% showed cytological evidence ofanal HPV infec-
The perianal area was examined by naked eye and then with the colposcope before and after application of 5% acetic acid solution. Colposcopic findings were recorded and categorised as: (a) normal (no abnormalities detected); (b) condylomata acuminata present; (c) acetowhite epithelium only-no condylomata visible. All subjects then underwent proctoscopy with detailed examination of the anal canal by naked eye and then by means of the colposcope. Clinical findings, before and after application of acetic acid, were recorded as described previously for the perianal area.
Further brush samples were taken from condylomata and acetowhite areas or, in the case of subjects with no clinical abnormalities, from the anal verge and anal canal. These brush samples, together with the Cytobrush used for obtaining anal cytology, were immediately placed into Eppendorf tubes containing 0.5 ml of phosphate buffered saline (PBS), vortexed to dislodge cellular material and the brush discarded. These specimens were then snap frozen and stored in liquid nitrogen whilst awaiting processing for DNA hybridisation.
Biopsies tAnal intraepithelial neoplasia. rates may be methodological, possibly the result of using a brush to sample the anal canal rather than a wooden spatula9 or cotton wool swab. '8 Previous studies have reported positive anal cytology in 33%18 and 58%9 of patients without anal warts. Although this has been considered indicative of subclinical infection, the possibility that this may merely reflect poor cytological specificity has not been addressed. We suspect both factors may be relevant. Subclinical HPV infection may be identified as areas of epithelial whitening following the application of an acetic acid solution. Using this technique we have documented colposcopically visible subclinical anal HPV infection in 28% of our study group. Ninety per cent of these subjects demonstrated positive anal cytology. However, 81% of study group subjects with a colposcopically normal anal examination and 25% of our "normal" comparison group also yielded positive anal cytology. Since HPV DNA was detected in only 65% of patients with anal warts (perianal + anal canal) and 32% with acetowhite lesions our DNA hybridisation results do not help to resolve the question of anal cytology specificity. Our DNA hybridisation technique appears less sensitive than the in situ hybridisation method described in a previous study in which HPV DNA was found in 87% of anal warts.'3 However, our findings are comparable to the results of in situ filter hybridisation which documented HPV DNA in 62% of genital warts.'9 Our use of samples obtained by brushing lesions may, in some cases, have provided insufficient material for adequate DNA extraction and subsequent hybridisation. In addition, the sensitivity of DNA hybridisation will be influenced by the HPV genome copy per cell. It is worth noting that of the 34 study group patients with a colposcopically normal anal examination, 29% had HPV DNA detected.
In the present study the sensitivities of anal cytology and DNA hybridisation with respect to anal canal warts were found to be 98% and 71 % respectively. The sensitivity of cytology with respect to DNA hybridisation was 93%. As mentioned previously, cytological specificity cannot be ascertained from the current data. Although koilocytosis is considered pathognomonic of HPV infection220 this was rarely seen in anal smears, the most commonly encountered cellular changes being parakeratosis and binucleation. This observation is in agreement with a previous study. ' In conclusion, we have found that anal examination with the colposcope is a useful method for detecting subclinical HPV infection. Anal cytology may prove helpful as a screening method for detecting anal intraepithelial neoplasia; however, the specificity of the cytological criteria for anal HPV infection in the absence of AIN requires further study. Although 
